Standard BioTools CEO Michael Egholm Withholds 362,625 Shares for Taxes

What Happened Michael Egholm, President & CEO and a director of Standard BioTools (LAB), had 362,625 shares withheld on August 3, 2026 to satisfy tax withholding obligations tied to the vesting of restricted stock units. The shares were recorded at $0.87 each, for a total value of approximately $314,759. This transaction is a tax-withholding disposition (transaction code F), not an open-market sale or a new purchase.

Key Details

• Transaction date: 2026-08-03; filing date: 2026-08-04 (Form 4 accession 0001193125-26-333225) — appears timely.
• Price per share: $0.87; shares withheld/disposed: 362,625; total value ≈ $314,759.
• Shares owned after the transaction: not specified in the provided filing.
• Footnote: Shares were withheld to satisfy tax withholding on RSUs granted August 1, 2025 (original grant reported on Form 4 filed August 5, 2025).
• Transaction code: F (tax withholding).

Context This was a routine tax-withholding action tied to RSU vesting, where the company retains (withholds) shares to cover required taxes. Such withholdings are common and do not necessarily reflect the insider’s view of the stock — they are not the same as an open-market sale or a purchase.